Piramal Pharma Limited Expands Riverview, Michigan, Facility
12/10/2020
Company officials said the expansion of 25,000 square feet, which includes 8,500 square feet of production space, will be used for the development and manufacturing of Active Pharmaceutical Ingredients. It is expected that the expansion will add approximately twenty new hires to the site, bringing the total headcount to more than 180 employees.
Peter DeYoung, CEO, Piramal Pharma Solutions said, "Piramal Pharma Solutions' Riverview facility has a well-earned reputation as the preeminent leader in high potency APIs (HPAPIs), and this expansion is designed to ensure that we retain that position. It enables us to support our customers' immediate and long-term API needs, strengthens our presence in North America, and enhances our ability to serve patients around the world by delivering the best active ingredients in a timely manner."
With successful inspections by the US FDA and many European and Asian government agencies, PPS' Riverview facility has a stellar track record of regulatory compliance and is committed to maintaining the highest possible standards of environmental performance, health and safety, company officials said.
Project Announcements
Siemens Energy Plans Fort Payne, Alabama, Manufacturing Operations
02/09/2026
Preciball USA Plans Screven County, Georgia, Production Operations
02/09/2026
Mecad USA Plans Tulsa Port of Catoosa, Oklahoma, Manufacturing Campus
02/08/2026
Anduril Industries Plans Long Beach-Lakewood, California, Operations
02/08/2026
Dongwon Autopart Technology Plans Emanuel County, Georgia, Production Operations
02/07/2026
Quantum Machines Plans Chicago, Illinois, Operations
02/06/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026